<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shaw D</submitter><funding>National Institute for Health Research (NIHR)</funding><funding>University of Oxford</funding><funding>Wellcome Trust</funding><pagination>e582-e593</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10914672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The Invasive Respiratory Infection Surveillance (IRIS) Consortium was established to assess the impact of the COVID-19 pandemic on invasive diseases caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and Streptococcus agalactiae. We aimed to analyse the incidence and distribution of these diseases during the first 2 years of the COVID-19 pandemic compared to the 2 years preceding the pandemic.&lt;h4>Methods&lt;/h4>For this prospective analysis, laboratories in 30 countries and territories representing five continents submitted surveillance data from Jan 1, 2018, to Jan 2, 2022, to private projects within databases in PubMLST. The impact of COVID-19 containment measures on the overall number of cases was analysed, and changes in disease distribu</pubmed_abstract><journal>The Lancet. Digital health</journal><pubmed_title>Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium.</pubmed_title><pmcid>PMC10914672</pmcid><funding_grant_id>203141/Z/16/Z</funding_grant_id><funding_grant_id>206394/C/17/Z</funding_grant_id><funding_grant_id>218205</funding_grant_id><funding_grant_id>206394</funding_grant_id><funding_grant_id>218205/Z/19/Z</funding_grant_id><funding_grant_id>206394/Z/17/Z</funding_grant_id><pubmed_authors>Siira L</pubmed_authors><pubmed_authors>Cuypers L</pubmed_authors><pubmed_authors>Casanova C</pubmed_authors><pubmed_authors>Oftadeh S</pubmed_authors><pubmed_authors>Sintchenko V</pubmed_authors><pubmed_authors>Meiring S</pubmed_authors><pubmed_authors>Sloan M</pubmed_authors><pubmed_authors>Lam TT</pubmed_authors><pubmed_authors>Deghmane AE</pubmed_authors><pubmed_authors>Martin I</pubmed_authors><pubmed_authors>Perez-Vazquez M</pubmed_authors><pubmed_authors>Coelho J</pubmed_authors><pubmed_authors>Jolley KA</pubmed_authors><pubmed_authors>Claus H</pubmed_authors><pubmed_authors>Meehan M</pubmed_authors><pubmed_authors>Mzabi A</pubmed_authors><pubmed_authors>Ron M</pubmed_authors><pubmed_authors>Abad R</pubmed_authors><pubmed_authors>Kristinsson KG</pubmed_authors><pubmed_authors>Fuursted K</pubmed_authors><pubmed_authors>Humphreys H</pubmed_authors><pubmed_authors>van der Linden MPG</pubmed_authors><pubmed_authors>Henriques-Normark B</pubmed_authors><pubmed_authors>van Sorge NM</pubmed_authors><pubmed_authors>Johnston J</pubmed_authors><pubmed_authors>Davies H</pubmed_authors><pubmed_authors>McCarthy ND</pubmed_authors><pubmed_authors>Novakova L</pubmed_authors><pubmed_authors>Hoffmann S</pubmed_authors><pubmed_authors>Choi EH</pubmed_authors><pubmed_authors>Fry NK</pubmed_authors><pubmed_authors>Kozakova J</pubmed_authors><pubmed_authors>Ladhani S</pubmed_authors><pubmed_authors>Shaw D</pubmed_authors><pubmed_authors>Hilty M</pubmed_authors><pubmed_authors>Kuch A</pubmed_authors><pubmed_authors>Cao B</pubmed_authors><pubmed_authors>Smith AJ</pubmed_authors><pubmed_authors>Desmet S</pubmed_authors><pubmed_authors>Taha MK</pubmed_authors><pubmed_authors>Krizova P</pubmed_authors><pubmed_authors>Musilek M</pubmed_authors><pubmed_authors>Zhou F</pubmed_authors><pubmed_authors>Skoczynska A</pubmed_authors><pubmed_authors>Tzanakaki G</pubmed_authors><pubmed_authors>Hale T</pubmed_authors><pubmed_authors>du Plessis M</pubmed_authors><pubmed_authors>Corcoran M</pubmed_authors><pubmed_authors>Scott KJ</pubmed_authors><pubmed_authors>Drew R</pubmed_authors><pubmed_authors>Mulhall R</pubmed_authors><pubmed_authors>Litt D</pubmed_authors><pubmed_authors>Dalby T</pubmed_authors><pubmed_authors>Steens A</pubmed_authors><pubmed_authors>Roberts M</pubmed_authors><pubmed_authors>Toropainen M</pubmed_authors><pubmed_authors>Leon ME</pubmed_authors><pubmed_authors>Amin-Chowdhury Z</pubmed_authors><pubmed_authors>Sanabria OM</pubmed_authors><pubmed_authors>Murdoch D</pubmed_authors><pubmed_authors>Molling P</pubmed_authors><pubmed_authors>Lindholm L</pubmed_authors><pubmed_authors>Prevost B</pubmed_authors><pubmed_authors>Varon E</pubmed_authors><pubmed_authors>Perrin M</pubmed_authors><pubmed_authors>Ip M</pubmed_authors><pubmed_authors>Broughton K</pubmed_authors><pubmed_authors>Mattheus W</pubmed_authors><pubmed_authors>Zanella R</pubmed_authors><pubmed_authors>Domenech M</pubmed_authors><pubmed_authors>Rokney A</pubmed_authors><pubmed_authors>Cunney R</pubmed_authors><pubmed_authors>Vohrnova S</pubmed_authors><pubmed_authors>Yuste J</pubmed_authors><pubmed_authors>Slotved HC</pubmed_authors><pubmed_authors>Martiny D</pubmed_authors><pubmed_authors>Vainio A</pubmed_authors><pubmed_authors>Jacobsson S</pubmed_authors><pubmed_authors>Maiden MCJ</pubmed_authors><pubmed_authors>Henares D</pubmed_authors><pubmed_authors>Erlendsdottir H</pubmed_authors><pubmed_authors>Murphy J</pubmed_authors><pubmed_authors>von Gottberg A</pubmed_authors><pubmed_authors>Demczuk W</pubmed_authors><pubmed_authors>Johnson C</pubmed_authors><pubmed_authors>Morgan J</pubmed_authors><pubmed_authors>Perez-Arguello A</pubmed_authors><pubmed_authors>Brueggemann AB</pubmed_authors><pubmed_authors>Bennett D</pubmed_authors><pubmed_authors>Bautista A</pubmed_authors><pubmed_authors>Chu YW</pubmed_authors><pubmed_authors>Morfeldt E</pubmed_authors><pubmed_authors>Kawabata A</pubmed_authors><pubmed_authors>Munoz-Almagro C</pubmed_authors><pubmed_authors>Cottrell S</pubmed_authors><pubmed_authors>Perry M</pubmed_authors><pubmed_authors>Duarte C</pubmed_authors><pubmed_authors>de Gouveia L</pubmed_authors><pubmed_authors>Sheppard C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium.</name><description>&lt;h4>Background&lt;/h4>The Invasive Respiratory Infection Surveillance (IRIS) Consortium was established to assess the impact of the COVID-19 pandemic on invasive diseases caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and Streptococcus agalactiae. We aimed to analyse the incidence and distribution of these diseases during the first 2 years of the COVID-19 pandemic compared to the 2 years preceding the pandemic.&lt;h4>Methods&lt;/h4>For this prospective analysis, laboratories in 30 countries and territories representing five continents submitted surveillance data from Jan 1, 2018, to Jan 2, 2022, to private projects within databases in PubMLST. The impact of COVID-19 containment measures on the overall number of cases was analysed, and changes in disease distribu</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-06-09T07:00:06.733Z</modification><creation>2026-06-09T03:12:07.076Z</creation></dates><accession>S-EPMC10914672</accession><cross_references><pubmed>37516557</pubmed><doi>10.1016/S2589-7500(23)00108-5</doi></cross_references></HashMap>